首页 > 期刊杂志 > 正文

An update on the application of newly described immunohistochemical markers in soft tissue pathology.

软组织病理中新近描述的免疫组织化学标记物的应用

Abstract

During the last 5 to 10 years, significant progress has been made in the molecular characterization of soft tissue tumors, predominantly with the identification of recurrent translocations or amplification of certain genes in different tumor types. Alongside this, translational efforts have identified many novel and diagnostically useful immunohistochemical markers for many of these tumor types.
This article reviews a select group of recently described immunohistochemical markers of particular use in the evaluation of mesenchymal neoplasms; the underlying biology of the protein product, practical utility, and limitations of each marker are discussed in detail.
Literature review, authors' research data, and personal practice experience serve as sources.
There are many diagnostically useful immunohistochemical markers to help confirm the diagnosis of many different soft tissue tumor types, some of which have reduced the need for additional, and more costly, studies, such as fluorescence in situ hybridization. However, no one marker is 100% specific for a given tumor, and knowledge of potential pitfalls and overlap in patterns of staining among other tumor types is crucial to ensure the appropriate application of these markers in clinical practice.

摘要

过去5-10年间,软组织肿瘤的分子病理学取得了长足的进步,尤其是发现了不同肿瘤的特定基因异位突变或基因扩增。与此相伴,在许多这些肿瘤中,翻译出的新蛋白作为有诊断意义的免疫组织化学标记物也被发现出来。

本文回顾了一组新近描述用于评价间叶源性肿瘤的免疫组化标记物;详细讨论了每一种标记物相应蛋白的生物学、实际应用以及局限性。来源为文献,作者的研究数据以及个人实际工作经验。

有很多具有诊断价值的免疫组化标记物可帮助许多不同类型软组织肿瘤的确诊,部分可以减少使用额外的、更昂贵的检查方法,如FISH。但是,对于一个特定的肿瘤,没有一个标记物是100% 特异的,对于潜在陷阱以及与其它肿瘤染色模式重叠的了解是临床实际工作中合理应用这些标志物的关键。

full text

我要评论

0条评论